Insider transaction 📈 Stocks 🌍 United States

Webull President Denier Sells 53,846 Shares in Pre-Planned $516,000 Trade

Webull President Anthony Michael Denier offloaded 53,846 shares in a scheduled transaction, retaining a substantial equity stake in the $4.2 billion market cap firm despite recent share price volatility.

🕐 1 min read

1 assets impacted (Stocks). Net bias: 0 Bullish, 0 Bearish, 1 Neutral. Strongest signal: BULL → 2/10 (60% confidence).

📊 Affected Assets (1)

BULL
Neutral 🤖 60%
📅 Short-term 🌍 US · Explicit

President sold 53,846 shares under a pre-arranged 10b5-1 plan, retaining a 0.4% stake, so the sale is unlikely to materially affect the stock.

🎯 Key Takeaways

  • The sale of 53,846 shares was conducted via a Rule 10b5-1 plan, mitigating concerns regarding insider sentiment.
  • Denier retains 2,278,449 shares, representing a 0.4% stake in the company.
  • Webull shares have faced downward pressure, recording a 29% loss over the trailing twelve months.
  • Analysts remain bullish on the stock, with a median price target of $14.50.

📝 Executive Summary

Webull President Anthony Michael Denier sold 53,846 shares of the digital investment platform on September 8, 2026, for approximately $516,000. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan, signaling that the move was not a reactive sell-off. Despite a 29% decline in the stock over the past year, Denier retains a significant 2.2 million share stake, maintaining alignment with the firm's long-term performance.

❓ FAQ

Why did the Webull President sell shares?

The sale was executed under a pre-arranged Rule 10b5-1 trading plan established in May 2026, which allows insiders to sell shares according to a predetermined schedule to avoid potential conflicts regarding material non-public information.

Does this sale indicate a lack of confidence in Webull?

No, the sale was part of a pre-planned schedule and Denier continues to hold over 2.2 million shares, suggesting continued alignment with the company's long-term success.